This Alzheimer’s drug has already been approved for use in China. The clinical trials that could lead to approval in the U.S. have just…
The human body is host to trillions of microscopic organisms — collectively called the microbiome — that shape our health across the lifespan. This…
The ocean deep holds untapped potential when it comes to new therapies that could treat diseases like cancer and Alzheimer’s. But climate change and…
The Alzheimer’s Drug, Oligomannate, approved in China and derived from seaweed, is now being studied in the U.S. in a Phase 3, multi-center clinical…
While pharmaceutical companies have invested decades of research and billions of dollars in the quest to cure to Alzheimer’s, more than 100 experimental therapies…
Chinese officials announced conditional approval to a seaweed-based drug in November. Now, it’s available on the Chinese market. Oligomannate is the first drug to…
Was it too good to be true? China last week awarded conditional approval for a new seaweed-based drug for Alzheimer’s, but experts in the…
Building on research into the connection between dementia, inflammation and bacteria in our digestive systems, Chinese officials awarded conditional approval to a seaweed-based drug…